<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/"><channel><title>心血管高季刊</title><link/>https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;v=2.17.9.post6+86293ac&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-N Vu 8003KrCpq8yLQC-&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;ff=20230718143148&amp;fc= 20230708114047&amp;utm_source = Chrome<description>心血管高季刊：PubMed 的最新结果</description><atom:link href="https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;v=2.17.9.post6+86293ac&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;ff=20230718143148&amp;fc=20230708114047&amp;utm_source=Chrome" rel="self"></atom:link><docs> http://www.rssboard.org/rss-specification</docs><generator> PubMed RSS 源 (2.17.9.post6+86293ac)</generator><language> zh</language><lastbuilddate> 2023 年 7 月 18 日星期二 18:31:48 +0000</lastbuilddate><pubDate> Tue, 18 Jul 2023 06:00:00 -0400</pubDate><ttl> 120</ttl><item><title>缺血试验中完全血运重建的影响</title><link/>https://pubmed.ncbi.nlm.nih.gov/37462593/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff = 20230718143148&amp;v=2.17.9.post6+86293ac<description>结论：如果实现 CR（尤其是 ACR），INV 策略的结果可能会得到改善（国际医学和侵入性方法比较健康有效性研究 [ISCHEMIA]；NCT01471522）。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> J Am Coll Cardiol. 2023 Jul 11​​:S0735-1097(23)06031-X. doi: 10.1016/j.jacc.2023.06.015. 印刷前在线。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">背景：在一些先前的研究中，解剖性完全血运重建（ACR）和功能性完全血运重建（FCR）与死亡和心肌梗死（MI）的减少有关。与接受侵入性（INV）患者相比，完全血运重建（CR）的影响保守（CON）管理策略尚未见报道。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">目的：在 ISCHEMIA（医疗和侵入性方法的健康有效性比较国际研究）试验中，在未接受冠状动脉旁路移植术的慢性冠心病患者中随机接受 INV 与 CON 治疗的患者中，我们检查了以下内容：1）ACR 和2) 与 CON 治疗相比，所有 INV 患者实现 CR 的潜在影响。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">方法：在独立的核心实验室评估INV组的ACR和FCR，检查INV患者CR的多变量调整结果，然后进行逆概率加权模型来估计所有INV患者获得CR后的治疗效果。与 CON 管理。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结果：1,824 名 INV 患者中，43.4% 和 58.4% 实现了 ACR 和 FCR。与不完全血运重建相比，ACR 与 4 年心血管死亡率或 MI 发生率降低相关。通过逆概率加权模型，对所有 2,296 名 INV 患者的 ACR 进行了比较2,498 名 CON 患者的研究与较低的 4 年心血管死亡或 MI 发生率相关（差异 -3.5；95% CI：-7.2% 至 0.0%）。相比之下，INV 减去心血管死亡或 MI 的事件发生率差异整个 ISCHEMIA 试验中的 CON 为 -2.4%。结果与 FCR 相似，但不太明显。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结论：如果实现 CR（尤其是 ACR），INV 策略的结果可能会得到改善（国际医学和侵入性方法比较健康有效性研究 [ISCHEMIA]；NCT01471522）。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37462593/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230718143148&v=2.17.9.post6+86293ac">37462593</a> | DOI： <a href=https://doi.org/10.1016/j.jacc.2023.06.015>10.1016/j.jacc.2023.06.015</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37462593</guid><pubDate> Tue, 18 Jul 2023 06:00:00 -0400</pubDate><dc:creator>格雷格·W·斯通</dc:creator><dc:creator>齐亚德·阿​​里</dc:creator><dc:creator>肖恩·M·奥布莱恩</dc:creator><dc:creator>——格蕾丝·罗兹</dc:creator><dc:creator>菲利普·杰内勒</dc:creator><dc:creator>斯里帕尔·班加罗尔</dc:creator><dc:creator>克雷顿·马夫罗马蒂斯</dc:creator><dc:creator>詹妮弗·霍斯特</dc:creator><dc:creator>奥维迪乌·德雷斯勒</dc:creator><dc:creator>鲍建强</dc:creator><dc:creator>兰吉特·纳斯</dc:creator><dc:creator>纳加拉惹穆迪</dc:creator><dc:creator>亚当·维特科斯基</dc:creator><dc:creator>苏丹舒·德维迪</dc:creator><dc:creator>奥尔加·博克里亚</dc:creator><dc:creator>陈吉彦</dc:creator><dc:creator>保拉·EP·斯马尼奥</dc:creator><dc:creator>迈克尔·H·皮卡德</dc:creator><dc:creator>伯纳德·R·柴特曼</dc:creator><dc:creator>——丹尼尔·S·伯曼</dc:creator><dc:creator>莱斯利·J·肖</dc:creator><dc:creator>威廉·博登</dc:creator><dc:creator>哈维·D·怀特</dc:creator><dc:creator>斯蒂芬·E·弗雷姆斯</dc:creator><dc:creator>伊夫·罗森伯格</dc:creator><dc:creator>哈莫尼·R·雷诺兹</dc:creator><dc:creator>约翰·斯珀图斯</dc:creator><dc:creator>——朱迪思·S·霍克曼</dc:creator><dc:creator>——大卫·J·马龙</dc:creator><dc:creator>缺血研究组</dc:creator><dc:date>2023-07-18</dc:date><dc:source>美国心脏病学会杂志</dc:source><dc:title>缺血试验中完全血运重建的影响</dc:title><dc:identifier>下午：37462593</dc:identifier><dc:identifier> doi:10.1016/j.jacc.2023.06.015</dc:identifier></item><item><title>棕色脂肪组织和 BMP3b 减少心脏缺血再灌注损伤</title><link/>https://pubmed.ncbi.nlm.nih.gov/37462036/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff = 20230718143148&amp;v=2.17.9.post6+86293ac<description>结论：本研究的结果表明，BAT 和 BMP3b（一种由 BAT 分泌的蛋白质）在 I/R 损伤模型中具有心脏保护作用。增加 BMP3b 水平或靶向 Smad 1/5 的干预措施可能代表减少心肌损伤的新治疗方法在 I/R 损伤中。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> Circ Res. 2023 年 7 月 18 日。doi：10.1161/CIRCRESAHA.122.322337。印刷前在线。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">背景：尽管治疗取得了进展，心肌梗死 (MI) 仍是全世界心力衰竭和死亡的主要原因，缺血和再灌注 (I/R) 都会导致心脏损伤。之前使用非再灌注 MI 小鼠模型进行的一项研究表明，心肌梗死 (MI) 激活棕色脂肪组织 (BAT)。最近的研究表明，BAT 分泌的分子靶向心脏。我们研究了 BAT 是否可以减轻 I/R 中的心脏损伤，并试图鉴定 BAT 分泌的潜在心脏保护蛋白。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">方法：在野生型 (WT) 小鼠和 BAT 功能受损的小鼠（解偶联蛋白 1 [ <i>Ucp1</i> ] 缺陷小鼠）中进行有或没有 BAT 移植的心肌 I/R 手术。为了鉴定 BAT 产生的潜在心脏保护因子，在 WT 和<i>Ucp1</i> <sup><i>-</i></sup> <sup><i>/-</i></sup>小鼠的 BAT 中进行 RNA- <i>seq。R</i>使用 BMP3b 进行处理。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结果：小鼠 BAT 功能障碍与 I/R 后 MI 增大有关；相反，通过移植增加 BAT 会减小 MI 大小。我们确定 Bmp3b 是 I/R 后 BAT 分泌的蛋白质。与 WT 小鼠相比， <i>Bmp3b</i>缺陷的小鼠通过将 WT 小鼠的 BAT 移植到<i>Bmp3b</i>缺陷型小鼠中，增加功能性 BAT 可减少 I/R 损伤，而从<i>Bmp3b</i>缺陷型小鼠中移植 BAT 则不会。再灌注前用 BMP3b 处理 WT 小鼠可降低 MI 大小。BMP3b 的 MI 大小是通过 SMAD1/5 介导的/8. 在人类中，MI后血浆BMP3b水平升高，且与心脏损伤程度呈正相关。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结论：本研究的结果表明，BAT 和 BMP3b（一种由 BAT 分泌的蛋白质）在 I/R 损伤模型中具有心脏保护作用。增加 BMP3b 水平或靶向 Smad 1/5 的干预措施可能代表减少心肌损伤的新治疗方法在 I/R 损伤中。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37462036/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230718143148&v=2.17.9.post6+86293ac">37462036</a> | DOI： <a href=https://doi.org/10.1161/CIRCRESAHA.122.322337>10.1161/CIRCRESAHA.122.322337</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37462036</guid><pubDate> Tue, 18 Jul 2023 06:00:00 -0400</pubDate><dc:creator>英格丽德·马蒂·帕米斯</dc:creator><dc:creator>罗布雷希特·图南</dc:creator><dc:creator>迈克尔·莫利</dc:creator><dc:creator>劳伦·格雷夫斯</dc:creator><dc:creator>赫苏斯·塔梅兹</dc:creator><dc:creator>亚历克斯·卡普兰</dc:creator><dc:creator>肯德拉·麦克戴德</dc:creator><dc:creator>姚文森</dc:creator><dc:creator>艾莉森·欣德尔</dc:creator><dc:creator>罗伯特·E·格斯坦</dc:creator><dc:creator>劳里·法雷尔</dc:creator><dc:creator>李莉</dc:creator><dc:creator>曾玉华</dc:creator><dc:creator>格森·普罗菲塔</dc:creator><dc:creator>伊曼纽尔·S·购买</dc:creator><dc:creator>唐纳德·B·布洛赫</dc:creator><dc:creator>玛丽埃尔·谢勒-克罗斯比</dc:creator><dc:date>2023-07-18</dc:date><dc:source>流通研究</dc:source><dc:title>棕色脂肪组织和 BMP3b 减少心脏缺血再灌注损伤</dc:title><dc:identifier>下午：37462036</dc:identifier><dc:identifier> doi:10.1161/CIRCRESAHA.122.322337</dc:identifier></item><item><title>乳糜微粒调节乳汁渗透性和肠道脂质吸收</title><link/>https://pubmed.ncbi.nlm.nih.gov/37462027/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff = 20230718143148&amp;v=2.17.9.post6+86293ac<description>结论：我们的结果表明，ROCK 依赖性细胞骨架收缩的拮抗输入调节肠道和其他组织中淋巴连接的相互转换，提供了控制淋巴屏障的可调机制。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> Circ Res. 2023 年 7 月 18 日。doi：10.1161/CIRCRESAHA.123.322607。印刷前在线。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">背景：淋巴管负责组织引流，其功能障碍与慢性疾病有关。众所周知，淋巴管的摄取是通过毛细淋巴管内皮细胞 (LEC) 之间专门的开放细胞-细胞连接进行的，而收集 LEC 时的闭合连接可防止淋巴液渗漏。在发育和疾病中动态重塑，但淋巴通透性是如何调节的仍然知之甚少。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">方法：我们使用各种基因工程小鼠模型，结合细胞、生化和分子生物学方法来阐明调节毛细淋巴管连接形态和功能的信号通路。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结果：通过研究肠乳毛细血管对称为乳糜微粒的脂蛋白颗粒的通透性，我们表明 ROCK（Rho 相关激酶）依赖性细胞骨架收缩性是 LEC 通透性调节的基本机制。锚定应力纤维。LEC 特异性 ROCK 缺失消除了连接开放和血浆脂质摄取。乳糜微粒还抑制 VEGF（血管内皮生长因子）-A 信号传导。通过 VEGFR（VEGF 受体）2 和 VEGFR3 依赖性 PI3K/AKT 激活小GTPase RAC1，从而限制 RhoA/ROCK 介导的细胞骨架收缩。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结论：我们的结果表明，ROCK 依赖性细胞骨架收缩的拮抗输入调节肠道和其他组织中淋巴连接的相互转换，提供了控制淋巴屏障的可调机制。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37462027/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230718143148&v=2.17.9.post6+86293ac">37462027</a> | DOI： <a href=https://doi.org/10.1161/CIRCRESAHA.123.322607>10.1161/CIRCRESAHA.123.322607</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37462027</guid><pubDate> Tue, 18 Jul 2023 06:00:00 -0400</pubDate><dc:creator>乔治亚·扎卡达</dc:creator><dc:creator>陈迅</dc:creator><dc:creator>周学桐</dc:creator><dc:creator>马丁·兰格</dc:creator><dc:creator>曾雷</dc:creator><dc:creator>文宇Lv.</dc:creator><dc:creator>张旋</dc:creator><dc:creator>李云华</dc:creator><dc:creator>周伟斌</dc:creator><dc:creator>刘克利</dc:creator><dc:creator>陈东英</dc:creator><dc:creator>尼古拉斯·里卡德</dc:creator><dc:creator>廖詹姆斯</dc:creator><dc:creator>金英范</dc:creator><dc:creator>鲁伊·贝内迪托</dc:creator><dc:creator>莉娜·克莱森-威尔士</dc:creator><dc:creator>卡里·阿利塔洛</dc:creator><dc:creator>迈克尔·西蒙斯</dc:creator><dc:creator>容菊</dc:creator><dc:creator>李旭日</dc:creator><dc:creator>安妮·艾希曼</dc:creator><dc:creator>张峰</dc:creator><dc:date>2023-07-18</dc:date><dc:source>流通研究</dc:source><dc:title>乳糜微粒调节乳汁渗透性和肠道脂质吸收</dc:title><dc:identifier>下午：37462027</dc:identifier><dc:identifier> doi:10.1161/CIRCRESAHA.123.322607</dc:identifier></item><item><title>脊髓损伤个体心血管风险的诊断和管理：叙述性回顾</title><link/>https://pubmed.ncbi.nlm.nih.gov/37459417/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff = 20230718143148&amp;v=2.17.9.post6+86293ac<description>每年有超过 16 000 名美国人经历脊髓损伤 (SCI)，导致慢性残疾和其他继发后遗症。急性医疗管理的改进提高了预期寿命。心血管疾病是该人群的主要原因，并且似乎与一般人群相比，SCI 患者发生得更早。SCI 患者承受着传统心血管疾病危险因素的沉重负担，包括血脂异常和糖尿病等。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>流通</b>. 2023 年 7 月 18 日；148(3):268-277. doi: 10.1161/CIRCULATIONAHA.123.064859. Epub 2023 年 7 月 17 日。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">每年有超过 16 000 名美国人经历脊髓损伤 (SCI)，导致慢性残疾和其他继发后遗症。急性医疗管理的改进提高了预期寿命。心血管疾病是该人群的主要原因，并且似乎与一般人群相比，SCI 患者发生得更早。SCI 患者承受着传统心血管疾病危险因素的沉重负担，包括血脂异常和糖尿病，并且表现出解剖、代谢和生理变化，同时受伤后体力活动明显减少。经历与残疾相关的多重、复杂的护理障碍，并且在许多情况下，种族和社会经济健康不平等的交叉影响产生复合效应。考虑到这些危险因素的组合，一些研究人员提出，脊髓损伤患者患心血管疾病的风险增加，超出了其他疾病的风险。与传统风险因素相关的 SCI 可以被视为风险增强因素，类似于 2019 年美国心脏协会/美国心脏病学会一级预防指南定义的其他风险增强因素。人群阐明传统风险因素的作用、新的危险因素、医疗保健的获取、健康的社会决定因素以及残疾、种族和社会经济地位的交叉性。及时诊断和管理 SCI 患者心脏危险因素的重要性。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37459417/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230718143148&v=2.17.9.post6+86293ac">37459417</a> | DOI： <a href=https://doi.org/10.1161/CIRCULATIONAHA.123.064859>10.1161/CIRCULATIONAHA.123.064859</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37459417</guid><pubDate> Mon, 17 Jul 2023 06:00:00 -0400</pubDate><dc:creator>塔拉拉古</dc:creator><dc:creator>萨曼莎·L·施罗斯</dc:creator><dc:creator>卡罗尔·海伍德</dc:creator><dc:creator>艾伦·海涅曼</dc:creator><dc:creator>艾莉森·凯斯勒</dc:creator><dc:creator>莱斯利·莫尔斯</dc:creator><dc:creator>萨迪亚·汗</dc:creator><dc:creator>基亚里·N·克肖</dc:creator><dc:creator>马克·S·纳什</dc:creator><dc:date>2023-07-17</dc:date><dc:source>循环</dc:source><dc:title>脊髓损伤个体心血管风险的诊断和管理：叙述性回顾</dc:title><dc:identifier>下午：37459417</dc:identifier><dc:identifier> doi:10.1161/循环AHA.123.064859</dc:identifier></item><item><title>促进心源性猝死预防的公平性：谨防对初级预防植入式心脏复律除颤器在黑人患者中的有效性做出假设</title><link/>https://pubmed.ncbi.nlm.nih.gov/37459416/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff = 20230718143148&amp;v=2.17.9.post6+86293ac<description>没有摘要</description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>流通</b>. 2023 年 7 月 18 日；148(3):253-255. doi: 10.1161/CIRCULATIONAHA.123.065723. Epub 2023 年 7 月 17 日。</p><p><b>无摘要</b></p><p style="color: lightgray">PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37459416/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230718143148&v=2.17.9.post6+86293ac">37459416</a> | DOI： <a href=https://doi.org/10.1161/CIRCULATIONAHA.123.065723>10.1161 / CIRCULATIONAHA.123.065723</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37459416</guid><pubDate> Mon, 17 Jul 2023 06:00:00 -0400</pubDate><dc:creator>萨纳·哈提布</dc:creator><dc:creator>——凯文·托马斯</dc:creator><dc:date>2023-07-17</dc:date><dc:source>循环</dc:source><dc:title>促进心源性猝死预防的公平性：谨防对初级预防植入式心脏复律除颤器在黑人患者中的有效性做出假设</dc:title><dc:identifier>下午：37459416</dc:identifier><dc:identifier> doi:10.1161/循环AHA.123.065723</dc:identifier></item><item><title> 2015 年至 2021 年 ST 段抬高型心肌梗死过程指标和死亡率的种族差异：对美国心脏协会 178 062 名遵循冠状动脉疾病登记指南的患者进行的分析</title><link/>https://pubmed.ncbi.nlm.nih.gov/37459415/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff = 20230718143148&amp;v=2.17.9.post6+86293ac<description>结论：女性和男性的 STEMI 过程指标中仍然存在基于种族或民族的差异，与非西班牙裔白人女性相比，西班牙裔白人的死亡率存在差异。进一步的研究对于发展护理系统以减轻种族差异至关重要。 STEMI 结果。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>流通</b>. 2023 年 7 月 18 日；148(3):229-240. doi: 10.1161/CIRCULATIONAHA.123.065512. Epub 2023 年 7 月 17 日。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">背景：美国各地已开发出护理系统，以标准化护理流程并改善 ST 段抬高型心肌梗死 (STEMI) 患者的预后。STEMI 的治疗目标和死亡率尚不确定。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">方法：我们分析了 2015 年 1 月 1 日至 2021 年 12 月 31 日期间登记在美国心脏协会指南-冠状动脉疾病登记处的 178 062 名 STEMI 患者（52 293 名女性和 125 769 名男性）。患者被分为比较 3 个种族和民族的结果：非西班牙裔白人、西班牙裔白人和黑人。主要结果是达到以下 STEMI 过程指标的患者比例：通过紧急医疗服务获得的院前心电图；到达医院后 10 天内获得的心电图到达经皮冠状动脉介入治疗的时间在 90 分钟内；首次医疗接触设备的时间在 90 分钟内。次要结果是院内死亡率。对女性和男性分别进行分析，所有结果均根据年龄、合并症、表现的敏锐度、保险状况和社会经济状况，通过基于患者居住县的社会脆弱性指数来衡量。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结果：与患有 STEMI 的非西班牙裔白人患者相比，西班牙裔白人患者和黑人患者接受院前心电图以及实现上门心电图、上门到设备和首次医疗接触设备目标的几率较低这些治疗目标的种族差异在女性和男性中均观察到，并且在多变量调整后在大多数情况下持续存在。与非西班牙裔白人女性相比，西班牙裔白人女性的调整后院内死亡率更高（比值比，1.39 [95 % CI ，1.12-1.72]），而黑人女性没有（比值比，0.88 [95% CI，0.74-1.03]）。比值比，0.99 [95% CI，0.82-1.18]）和黑人男性（比值比，0.96 [95% CI，0.85-1.09]）。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结论：女性和男性的 STEMI 过程指标中仍然存在基于种族或民族的差异，与非西班牙裔白人女性相比，西班牙裔白人的死亡率存在差异。进一步的研究对于发展护理系统以减轻种族差异至关重要。 STEMI 结果。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37459415/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230718143148&v=2.17.9.post6+86293ac">37459415</a> | DOI： <a href=https://doi.org/10.1161/CIRCULATIONAHA.123.065512>10.1161/CIRCULATIONAHA.123.065512</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37459415</guid><pubDate> Mon, 17 Jul 2023 06:00:00 -0400</pubDate><dc:creator>阿莎娜·奥修</dc:creator><dc:creator>马塞洛·F·费尔南德斯</dc:creator><dc:creator>Ram Poudel更多</dc:creator><dc:creator>詹姆斯·德莱莫斯</dc:creator><dc:creator>洪浩云</dc:creator><dc:creator>赵娟</dc:creator><dc:creator>沉力</dc:creator><dc:creator>——凯西·托马斯</dc:creator><dc:creator>丹尼尔·菊池</dc:creator><dc:creator>杰西卡·泽格雷-海姆西</dc:creator><dc:creator>纳斯里安·易卜拉欣</dc:creator><dc:creator>尼莱·S·沙阿</dc:creator><dc:creator>洛瑞·霍洛韦尔</dc:creator><dc:creator>杰奎琳·塔米斯-霍兰德</dc:creator><dc:creator>克里斯托弗·B·格兰杰</dc:creator><dc:creator>毛里西奥·科恩</dc:creator><dc:creator>蒂莫西·亨利</dc:creator><dc:creator>艾丽丝·雅各布斯</dc:creator><dc:creator>詹姆斯·G·乔利斯</dc:creator><dc:creator>克莱德·W·扬西</dc:creator><dc:creator>Abhinav Goyal更多</dc:creator><dc:date>2023-07-17</dc:date><dc:source>循环</dc:source><dc:title>2015 年至 2021 年 ST 段抬高型心肌梗死过程指标和死亡率的种族差异：对美国心脏协会 178 062 名遵循冠状动脉疾病登记指南的患者进行的分析</dc:title><dc:identifier>下午：37459415</dc:identifier><dc:identifier> doi:10.1161/循环AHA.123.065512</dc:identifier></item><item><title>解决心血管差异的复杂自适应系统仿真建模：复杂问题的复杂科学</title><link/>https://pubmed.ncbi.nlm.nih.gov/37459414/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff = 20230718143148&amp;v=2.17.9.post6+86293ac<description>没有摘要</description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>流通</b>. 2023 年 7 月 18 日；148(3):201-203. doi: 10.1161/CIRCULATIONAHA.122.061728. Epub 2023 年 7 月 17 日。</p><p><b>无摘要</b></p><p style="color: lightgray">PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37459414/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230718143148&v=2.17.9.post6+86293ac">37459414</a> | DOI： <a href=https://doi.org/10.1161/CIRCULATIONAHA.122.061728>10.1161/CIRCULATIONAHA.122.061728</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37459414</guid><pubDate> Mon, 17 Jul 2023 06:00:00 -0400</pubDate><dc:creator>卡迈勒·H·亨德森</dc:creator><dc:creator>罗斯·哈蒙德</dc:creator><dc:creator>杰克·B·霍默</dc:creator><dc:date>2023-07-17</dc:date><dc:source>循环</dc:source><dc:title>解决心血管差异的复杂自适应系统仿真建模：复杂问题的复杂科学</dc:title><dc:identifier>下午：37459414</dc:identifier><dc:identifier> doi:10.1161/循环AHA.122.061728</dc:identifier></item><item><title>使用一级预防除颤器的黑人患者和白人患者的心律失常和生存结果</title><link/>https://pubmed.ncbi.nlm.nih.gov/37459413/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff = 20230718143148&amp;v=2.17.9.post6+86293ac<description>结论：在采用 ICD 进行一级预防的 NICM 患者中，与白人患者相比，黑人患者接受 VTA、ATA 和 ICD 治疗的风险和负担较高，且生存率较低。与白人患者的情况相似。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>流通</b>. 2023 年 7 月 18 日；148(3):241-252. doi: 10.1161/CIRCULATIONAHA.123.065367. Epub 2023 年 7 月 17 日。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">背景：美国黑人患非缺血性心肌病 (NICM) 的风险高于美国白人。我们的目的是评估植入式心律转复除颤器 (ICD) 患者发生快速心律失常风险的差异。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">方法：研究人群包括参加初级预防 ICD 试验的 3895 名美国 ICD 接受者。结果指标包括室性快速心律失常 (VTA)、房性快速心律失常 (ATA)、ICD 治疗、VTA 负担（使用 Andersen-Gill 复发事件分析）、死亡以及 ICD 的预测获益。所有事件均采用盲法判定。对自我报告的患有心肌病（缺血性和 NICM）的黑人患者与白人患者的结果进行了比较。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结果：黑人患者更有可能是女性（35% 对比 22%）且更年轻（57±12 岁对比 62±12 岁），合并症的发生率更高。在 NICM 中，黑人患者首次 VTA 发生率更高，快速VTA、ATA 以及适当和不适当的 ICD 治疗（VTA ≥170 bpm，32% 对 20%；VTA ≥200 bpm，22% 对 14%；ATA，25% 对 12%；适当治疗，30% 对 20%；不适当的治疗，分别为 25% 与 11%；所有<i>P</i> &lt;0.001）。多变量分析显示，患有 NICM 的黑人患者发生所有类型心律失常或 ICD 治疗的风险较高（VTA ≥170 bpm，风险比 [HR] 1.71； VTA ≥200 bpm，HR 1.58；ATA，HR 1.87；适当的治疗，HR 1.62；不适当的治疗，HR 1.86；所有<i>P</i> ≤ 0.01），快速心律失常或治疗的负担较高（VTA，HR 1.84；两者<i>P</i> &lt;0.001） ，以及更高的死亡风险（HR 1.92； <i>P</i> = 0.014）。黑人和白人患者都从 ICD 植入中获得了显着且相似的益处。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结论：在采用 ICD 进行一级预防的 NICM 患者中，与白人患者相比，黑人患者接受 VTA、ATA 和 ICD 治疗的风险和负担较高，且生存率较低。与白人患者的情况相似。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37459413/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230718143148&v=2.17.9.post6+86293ac">37459413</a> | DOI： <a href=https://doi.org/10.1161/CIRCULATIONAHA.123.065367>10.1161/CIRCULATIONAHA.123.065367</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37459413</guid><pubDate> Mon, 17 Jul 2023 06:00:00 -0400</pubDate><dc:creator>阿尔瓦·尤尼斯</dc:creator><dc:creator>萨那·阿里</dc:creator><dc:creator>艾琳·希奇</dc:creator><dc:creator>伊多·戈登伯格</dc:creator><dc:creator>斯科特·麦克尼特</dc:creator><dc:creator>布罗尼斯拉娃·波隆斯基</dc:creator><dc:creator>穆罕默德·K·阿克塔斯</dc:creator><dc:creator>瓦伦蒂娜·库蒂法</dc:creator><dc:creator>乌萨马·M·瓦兹尼</dc:creator><dc:creator>沃伊切赫·扎雷巴</dc:creator><dc:creator>伊兰·戈登伯格</dc:creator><dc:date>2023-07-17</dc:date><dc:source>循环</dc:source><dc:title>使用一级预防除颤器的黑人患者和白人患者的心律失常和生存结果</dc:title><dc:identifier>下午：37459413</dc:identifier><dc:identifier> doi:10.1161/循环AHA.123.065367</dc:identifier></item><item><title>心血管临床试验中培养多样性和实现公平性的策略</title><link/>https://pubmed.ncbi.nlm.nih.gov/37459412/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff = 20230718143148&amp;v=2.17.9.post6+86293ac<description>没有摘要</description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>流通</b>. 2023 年 7 月 18 日；148(3):204-206. doi: 10.1161/CIRCULATIONAHA.123.065476. Epub 2023 年 7 月 17 日。</p><p><b>无摘要</b></p><p style="color: lightgray">PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37459412/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230718143148&v=2.17.9.post6+86293ac">37459412</a> | DOI： <a href=https://doi.org/10.1161/CIRCULATIONAHA.123.065476>10.1161/CIRCULATIONAHA.123.065476</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37459412</guid><pubDate> Mon, 17 Jul 2023 06:00:00 -0400</pubDate><dc:creator>黛布拉·迪克森</dc:creator><dc:creator>康苏埃洛·H·威尔金斯</dc:creator><dc:date>2023-07-17</dc:date><dc:source>循环</dc:source><dc:title>心血管临床试验中培养多样性和实现公平性的策略</dc:title><dc:identifier>下午：37459412</dc:identifier><dc:identifier> doi:10.1161/循环AHA.123.065476</dc:identifier></item><item><title>促进美国心血管健康公平：既然我们知道了，下一步该往哪里走？</title><link/> https://pubmed.ncbi.nlm.nih.gov/37459411/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff = 20230718143148&amp;v=2.17.9.post6+86293ac<description>没有摘要</description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>流通</b>. 2023 年 7 月 18 日；148(3):197-198. doi: 10.1161/CIRCULATIONAHA.123.065971. Epub 2023 年 7 月 17 日。</p><p><b>无摘要</b></p><p style="color: lightgray">PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37459411/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230718143148&v=2.17.9.post6+86293ac">37459411</a> | DOI： <a href=https://doi.org/10.1161/CIRCULATIONAHA.123.065971>10.1161/CIRCULATIONAHA.123.065971</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37459411</guid><pubDate> Mon, 17 Jul 2023 06:00:00 -0400</pubDate><dc:creator> Rishi K Wadhera更多</dc:creator><dc:creator>卡罗尔·E·沃森</dc:creator><dc:creator>梅赛德斯·R·卡内松</dc:creator><dc:date>2023-07-17</dc:date><dc:source>循环</dc:source><dc:title>促进美国心血管健康公平：既然我们知道了，下一步该往哪里走？</dc:title><dc:identifier>下午：37459411</dc:identifier><dc:identifier> doi:10.1161/循环AHA.123.065971</dc:identifier></item><item><title>美国心脏协会计划旨在提高西班牙裔或拉丁裔临床医生在心脏病学领域的代表性</title><link/>https://pubmed.ncbi.nlm.nih.gov/37459410/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff = 20230718143148&amp;v=2.17.9.post6+86293ac<description>没有摘要</description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>流通</b>. 2023 年 7 月 18 日；148(3):278-279. doi: 10.1161/CIRCULATIONAHA.123.064251. Epub 2023 年 7 月 17 日。</p><p><b>无摘要</b></p><p style="color: lightgray">PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37459410/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230718143148&v=2.17.9.post6+86293ac">37459410</a> | DOI： <a href=https://doi.org/10.1161/CIRCULATIONAHA.123.064251>10.1161/CIRCULATIONAHA.123.064251</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37459410</guid><pubDate> Mon, 17 Jul 2023 06:00:00 -0400</pubDate><dc:creator>布里奇特·M·库恩</dc:creator><dc:date>2023-07-17</dc:date><dc:source>循环</dc:source><dc:title>美国心脏协会计划旨在提高西班牙裔或拉丁裔临床医生在心脏病学领域的代表性</dc:title><dc:identifier>下午：37459410</dc:identifier><dc:identifier> doi:10.1161/循环AHA.123.064251</dc:identifier></item><item><title>医疗保险受益人的历史红线、社会经济困境和心力衰竭风险</title><link/>https://pubmed.ncbi.nlm.nih.gov/37459409/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff = 20230718143148&amp;v=2.17.9.post6+86293ac<description>结论：历史红线与黑人患者心力衰竭风险增加相关。当代邮政编码级别的健康社会决定因素改变了红线与心力衰竭风险之间的关系，在社会经济最弱势的社区中观察到红线与心力衰竭之间的关系最强。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>流通</b>. 2023 年 7 月 18 日；148(3):210-219. doi: 10.1161/CIRCULATIONAHA.123.064351. Epub 2023 年 7 月 17 日。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">背景：历史红线政策（结构性种族主义的标志）与当代白人和黑人心力衰竭（HF）风险之间的关联尚未明确。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">方法：我们旨在评估白人和黑人医疗保险受益人中红线与心力衰竭风险的关联。邮政编码级别的红线是根据每个邮政编码内使用映射不平等项目的历史红线区域的比例来确定的。邮政编码红线比例使用针对潜在混杂因素进行调整的广义线性混合模型（包括邮政编码级社会剥夺指数的衡量标准），对白人和黑人医疗保险受益人（四分位数 4 与四分位数 1-3）和心力衰竭风险分别进行评估。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结果：共纳入 2 388 955 名医疗保险受益人（黑人 n=801 452；白人 n=1 587 503；平均年龄 71 岁；男性 44.6%）。黑人受益人中，居住在红线比例较高的邮政编码地区调整年龄、性别和合并症后，（四分位数 4 与四分位数 1-3）与心力衰竭风险增加相关（风险比，1.08 [95% CI，1.04-1.12]； <i>P</i> &lt;0.001）。进一步调整面积-社会剥夺指数（风险比，1.04 [95% CI，1.002-1.08]； <i>P</i> = 0.04）。在红线比例和社会剥夺指数之间观察到显着的交互作用（ <i>P</i><sub>交互</sub>&lt;0.01），因此较高的红线比例显着相关仅在社会经济困难地区（高于社会剥夺指数中位数）存在心力衰竭风险。在白人受益人中，调整年龄、性别和合并症后，红线与心力衰竭风险较低相关（风险比，0.94 [ 95% CI，0.89] -0.99]； <i>P</i> = 0.02）。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结论：历史红线与黑人患者心力衰竭风险增加相关。当代邮政编码级别的健康社会决定因素改变了红线与心力衰竭风险之间的关系，在社会经济最弱势的社区中观察到红线与心力衰竭之间的关系最强。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37459409/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230718143148&v=2.17.9.post6+86293ac">37459409</a> | DOI： <a href=https://doi.org/10.1161/CIRCULATIONAHA.123.064351>10.1161/CIRCULATIONAHA.123.064351</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37459409</guid><pubDate> Mon, 17 Jul 2023 06:00:00 -0400</pubDate><dc:creator>阿姆加德·门蒂亚斯更多</dc:creator><dc:creator>Mahasin S Mujahid更多</dc:creator><dc:creator>——安德鲁·苏马索诺</dc:creator><dc:creator>——罗伯特·K·纳尔逊</dc:creator><dc:creator>贾斯汀·马德伦</dc:creator><dc:creator>蒂芙尼·M·鲍威尔-威利</dc:creator><dc:creator>乌蒂贝·R·埃辛</dc:creator><dc:creator>尼尔·凯什瓦尼</dc:creator><dc:creator>萨凯特·吉罗特拉</dc:creator><dc:creator>阿兰娜·莫里斯</dc:creator><dc:creator>马里奥·西姆斯</dc:creator><dc:creator>奎因·卡珀斯</dc:creator><dc:creator>克莱德·扬西</dc:creator><dc:creator>米林德·德赛</dc:creator><dc:creator>维努·梅农</dc:creator><dc:creator>施雷亚·拉奥</dc:creator><dc:creator>安巴里什·潘迪</dc:creator><dc:date>2023-07-17</dc:date><dc:source>循环</dc:source><dc:title>医疗保险受益人的历史红线、社会经济困境和心力衰竭风险</dc:title><dc:identifier>下午：37459409</dc:identifier><dc:identifier> doi:10.1161/循环AHA.123.064351</dc:identifier></item><item><title>首次心肌梗死后复发性动脉粥样硬化性心血管疾病事件的社会经济差异和中介因素</title><link/>https://pubmed.ncbi.nlm.nih.gov/37459408/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff = 20230718143148&amp;v=2.17.9.post6+86293ac<description>结论：不参与心脏康复、心脏代谢风险状况和持续吸烟介导 MI 后收入依赖的预后。在缺乏随机试验的情况下，这种因果推理方法可能会指导改善健康公平的决策。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>流通</b>. 2023 年 7 月 18 日；148(3):256-267. doi: 10.1161/CIRCULATIONAHA.123.064440. Epub 2023 年 7 月 17 日。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">背景：低社会经济地位与心肌梗死 (MI) 后较差的二级预防使用和预后相关。改善健康公平的行动需要确定风险中介因素。因此，我们评估了社会经济地位与首次复发性动脉粥样硬化性心血管疾病事件之间关联的中介因素MI 后 (rASCVD)。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">方法：在这项针对瑞典全民健康覆盖年龄 18 至 76 岁的首例心肌梗死 1 年幸存者的队列研究中，来自 SWEDEHEART（瑞典心脏病循证护理增强和发展网络系统）的个人数据根据推荐疗法）和链接的国家登记处收集了 2006 年至 2020 年期间的数据。暴露程度是按可支配收入五分位（主要代表）、教育水平和婚姻状况划分的社会经济状况。主要结局是 rASCVD，次要结局是心血管疾病和全因疾病我们最初在序贯多变量模型中评估了风险比的增量衰减，其中 95% CI 添加了潜在介质组（即既往危险因素、急性表现和梗死严重程度、初始治疗和二级预防）。使用因果中介分析计算出因不参与心脏康复、次优他汀类药物管理、心脏代谢风险状况、持续吸烟和心肌梗死后血压高于目标而介导的因素。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结果：在 68 775 名参与者（73.8% 男性）中，平均 5.7 年的随访期间发生了 7064 例 rASCVD。根据年龄、性别和历年调整后的收入与 rASCVD 相关（风险比为 1.63 [95% CI]通过调整先前的风险因素以及为最终模型添加二级预防变量（最低收入五分之一与最高收入五分之一的风险比为 1.38 [95% CI，1.26-1.51]），风险得到最大程度的减弱。最低收入五分之一与最高收入五分之一。在收入最低的五分之一中，由于不参与心脏康复、心脏代谢风险状况、持续吸烟和血压控制不良而导致的 15 年 rASCVD 风险过高的比例分别为 3.3% (95% CI 2.1-4.8)、3.9% (95分别为 % CI，2.9-5.5)、15.2% (95% CI 0.6-1.5) 和 1.0% (95% CI 0.6-1.5)。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结论：不参与心脏康复、心脏代谢风险状况和持续吸烟介导 MI 后收入依赖的预后。在缺乏随机试验的情况下，这种因果推理方法可能会指导改善健康公平的决策。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37459408/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230718143148&v=2.17.9.post6+86293ac">37459408</a> | DOI： <a href=https://doi.org/10.1161/CIRCULATIONAHA.123.064440>10.1161/CIRCULATIONAHA.123.064440</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37459408</guid><pubDate> Mon, 17 Jul 2023 06:00:00 -0400</pubDate><dc:creator>乔尔·欧姆</dc:creator><dc:creator>拉尔夫·库贾-哈尔科拉</dc:creator><dc:creator>安娜·沃恩奎斯特</dc:creator><dc:creator>亨利克·哈贝尔</dc:creator><dc:creator>Per H Skoglund</dc:creator><dc:creator> Johan Sundström</dc:creator><dc:creator> Kristina Hambraeus</dc:creator><dc:creator> Tomas Jernberg</dc:creator><dc:creator> Per Svensson</dc:creator><dc:date> 2023-07-17</dc:date><dc:source> Circulation</dc:source><dc:title> Socioeconomic Disparities and Mediators for Recurrent Atherosclerotic Cardiovascular Disease Events After a First Myocardial Infarction</dc:title><dc:identifier> pmid:37459408</dc:identifier><dc:identifier> doi:10.1161/CIRCULATIONAHA.123.064440</dc:identifier></item><item><title> Associations Between Maternal Sociodemographics and Hospital Mortality in Newborns With Prenatally Diagnosed Hypoplastic Left Heart Syndrome</title><link/> https://pubmed.ncbi.nlm.nih.gov/37459407/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230718143148&amp;v=2.17.9.post6+86293ac<description> No abstract </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> <b>Circulation</b> . 2023 Jul 18;148(3):283-285. doi: 10.1161/CIRCULATIONAHA.123.064476. Epub 2023 Jul 17.</p><p> <b>NO ABSTRACT</b></p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/37459407/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230718143148&v=2.17.9.post6+86293ac">37459407</a> | DOI: <a href=https://doi.org/10.1161/CIRCULATIONAHA.123.064476>10.1161/CIRCULATIONAHA.123.064476</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:37459407</guid><pubDate> Mon, 17 Jul 2023 06:00:00 -0400</pubDate><dc:creator> Keila N Lopez</dc:creator><dc:creator> Shaine A Morris</dc:creator><dc:creator> Anita Krishnan</dc:creator><dc:creator> Marni B Jacobs</dc:creator><dc:creator> Aarti H Bhat</dc:creator><dc:creator> Anjali Chelliah</dc:creator><dc:creator> Joanne S Chiu</dc:creator><dc:creator> Bettina F Cuneo</dc:creator><dc:creator> Grace Freire</dc:creator><dc:creator> Lisa K Hornberger</dc:creator><dc:creator> Lisa Howley</dc:creator><dc:creator> Nazia Husain</dc:creator><dc:creator> Catherine Ikemba</dc:creator><dc:creator> Ann Kavanaugh-McHugh</dc:creator><dc:creator> Shelby Kutty</dc:creator><dc:creator> Caroline Lee</dc:creator><dc:creator> Angela McBrien</dc:creator><dc:creator> Erik C Michelfelder</dc:creator><dc:creator> Nelangi M Pinto</dc:creator><dc:creator> Rachel Schwartz</dc:creator><dc:creator> Kenan WD Stern</dc:creator><dc:creator> Carolyn Taylor</dc:creator><dc:creator> Varsha Thakur</dc:creator><dc:creator> Wayne Tworetzky</dc:creator><dc:creator> Carol Wittlieb-Weber</dc:creator><dc:creator> Kris Woldu</dc:creator><dc:creator> Mary T Donofrio</dc:creator><dc:creator> Shabnam Peyvandi</dc:creator><dc:creator> Fetal Heart Society Research Collaborative</dc:creator><dc:date> 2023-07-17</dc:date><dc:source> Circulation</dc:source><dc:title> Associations Between Maternal Sociodemographics and Hospital Mortality in Newborns With Prenatally Diagnosed Hypoplastic Left Heart Syndrome</dc:title><dc:identifier> pmid:37459407</dc:identifier><dc:identifier> doi:10.1161/CIRCULATIONAHA.123.064476</dc:identifier></item><item><title> The Time to Act Is Now: Racial Disparities After Heart Transplantation</title><link/> https://pubmed.ncbi.nlm.nih.gov/37459406/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230718143148&amp;v=2.17.9.post6+86293ac<description> No abstract </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> <b>Circulation</b> . 2023 Jul 18;148(3):207-209. doi: 10.1161/CIRCULATIONAHA.123.064499. Epub 2023 Jul 17.</p><p> <b>NO ABSTRACT</b></p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/37459406/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230718143148&v=2.17.9.post6+86293ac">37459406</a> | DOI: <a href=https://doi.org/10.1161/CIRCULATIONAHA.123.064499>10.1161/CIRCULATIONAHA.123.064499</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:37459406</guid><pubDate> Mon, 17 Jul 2023 06:00:00 -0400</pubDate><dc:creator> Kiran K Khush</dc:creator><dc:creator> Hannah A Valantine</dc:creator><dc:date> 2023-07-17</dc:date><dc:source> Circulation</dc:source><dc:title> The Time to Act Is Now: Racial Disparities After Heart Transplantation</dc:title><dc:identifier> pmid:37459406</dc:identifier><dc:identifier> doi:10.1161/CIRCULATIONAHA.123.064499</dc:identifier></item><item><title> Historical Neighborhood Redlining and Cardiovascular Risk in Patients With Chronic Kidney Disease</title><link/> https://pubmed.ncbi.nlm.nih.gov/37459405/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230718143148&amp;v=2.17.9.post6+86293ac<description> No abstract </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> <b>Circulation</b> . 2023 Jul 18;148(3):280-282. doi: 10.1161/CIRCULATIONAHA.123.064215. Epub 2023 Jul 17.</p><p> <b>NO ABSTRACT</b></p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/37459405/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230718143148&v=2.17.9.post6+86293ac">37459405</a> | DOI: <a href=https://doi.org/10.1161/CIRCULATIONAHA.123.064215>10.1161/CIRCULATIONAHA.123.064215</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:37459405</guid><pubDate> Mon, 17 Jul 2023 06:00:00 -0400</pubDate><dc:creator> Sadeer Al-Kindi</dc:creator><dc:creator> Issam Motairek</dc:creator><dc:creator> Catherine Kreatsoulas</dc:creator><dc:creator> Jackson T Wright</dc:creator><dc:creator> Mirela Dobre</dc:creator><dc:creator> Mahboob Rahman</dc:creator><dc:creator> Sanjay Rajagopalan</dc:creator><dc:date> 2023-07-17</dc:date><dc:source> Circulation</dc:source><dc:title> Historical Neighborhood Redlining and Cardiovascular Risk in Patients With Chronic Kidney Disease</dc:title><dc:identifier> pmid:37459405</dc:identifier><dc:identifier> doi:10.1161/CIRCULATIONAHA.123.064215</dc:identifier></item><item><title> Cardiopulmonary Impact of Electronic Cigarettes and Vaping Products: A Scientific Statement From the American Heart Association</title><link/> https://pubmed.ncbi.nlm.nih.gov/37458106/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230718143148&amp;v=2.17.9.post6+86293ac<description> Vaping and electronic cigarette (e-cigarette) use have grown exponentially in the past decade, particularly among youth and young adults. Cigarette smoking is a risk factor for both cardiovascular and pulmonary disease. Because of their more limited ingredients and the absence of combustion, e-cigarettes and vaping products are often touted as safer alternative and potential tobacco-cessation products. The outbreak of e-cigarette or vaping product use-associated lung injury in the United States... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> <b>Circulation</b> . 2023 Jul 17. doi: 10.1161/CIR.0000000000001160. Online ahead of print.</p><p> <b>ABSTRACT</b> </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> Vaping and electronic cigarette (e-cigarette) use have grown exponentially in the past decade, particularly among youth and young adults. Cigarette smoking is a risk factor for both cardiovascular and pulmonary disease. Because of their more limited ingredients and the absence of combustion, e-cigarettes and vaping products are often touted as safer alternative and potential tobacco-cessation products. The outbreak of e-cigarette or vaping product use-associated lung injury in the United States in 2019, which led to >;2800 hospitalizations, highlighted the risks of e-cigarettes and vaping products. Currently, all e-cigarettes are regulated as tobacco products and thus do not undergo the premarket animal and human safety studies required of a drug product or medical device. Because youth prevalence of e-cigarette and vaping product use was as high as 27.5% in high school students in 2019 in the United States, it is critical to assess the short-term and long-term health effects of these products, as well as the development of interventional and public health efforts to reduce youth use. The objectives of this scientific statement are (1) to describe and discuss e-cigarettes and vaping products use patterns among youth and adults; (2) to identify harmful and potentially harmful constituents in vaping aerosols; (3) to critically assess the molecular, animal, and clinical evidence on the acute and chronic cardiovascular and pulmonary risks of e-cigarette and vaping products use; (4) to describe the current evidence of e-cigarettes and vaping products as potential tobacco-cessation products; and (5) to summarize current public health and regulatory efforts of e-cigarettes and vaping products. It is timely, therefore, to review the short-term and especially the long-term implications of e-cigarettes and vaping products on cardiopulmonary health. Early molecular and clinical evidence suggests various acute physiological effects from electronic nicotine delivery systems, particularly those containing nicotine. Additional clinical and animal-exposure model research is critically needed as the use of these products continues to grow.</p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/37458106/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230718143148&v=2.17.9.post6+86293ac">37458106</a> | DOI: <a href=https://doi.org/10.1161/CIR.0000000000001160>10.1161/CIR.0000000000001160</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:37458106</guid><pubDate> Mon, 17 Jul 2023 06:00:00 -0400</pubDate><dc:creator> Jason J Rose</dc:creator><dc:creator> Suchitra Krishnan-Sarin</dc:creator><dc:creator> Vernat J Exil</dc:creator><dc:creator> Naomi M Hamburg</dc:creator><dc:creator> Jessica L Fetterman</dc:creator><dc:creator> Fumito Ichinose</dc:creator><dc:creator> Miguel A Perez-Pinzon</dc:creator><dc:creator> Mary Rezk-Hanna</dc:creator><dc:creator> Eric Williamson</dc:creator><dc:creator> American Heart Association Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation; Council on Epidemiology and Prevention; Council on Cardiovascular Radiology and Intervention; Council on Lifestyle and Cardiometabolic Health; Council on Peripheral Vascular Disease; Stroke Council; and Council on Arteriosclerosis, Thrombosis and Vascular Biology</dc:creator><dc:date> 2023-07-17</dc:date><dc:source> Circulation</dc:source><dc:title> Cardiopulmonary Impact of Electronic Cigarettes and Vaping Products: A Scientific Statement From the American Heart Association</dc:title><dc:identifier> pmid:37458106</dc:identifier><dc:identifier> doi:10.1161/CIR.0000000000001160</dc:identifier></item><item><title> New recommendations of the International Committee of Medical Journal Editors: use of artificial intelligence</title><link/> https://pubmed.ncbi.nlm.nih.gov/37453047/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230718143148&amp;v=2.17.9.post6+86293ac<description> No abstract </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> Eur Heart J. 2023 Jul 15:ehad448. doi: 10.1093/eurheartj/ehad448. Online ahead of print.</p><p> <b>NO ABSTRACT</b></p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/37453047/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230718143148&v=2.17.9.post6+86293ac">37453047</a> | DOI: <a href=https://doi.org/10.1093/eurheartj/ehad448>10.1093/eurheartj/ehad448</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:37453047</guid><pubDate> Sat, 15 Jul 2023 06:00:00 -0400</pubDate><dc:creator> Fernando Alfonso</dc:creator><dc:creator> Filippo Crea</dc:creator><dc:date> 2023-07-15</dc:date><dc:source> European heart journal</dc:source><dc:title> New recommendations of the International Committee of Medical Journal Editors: use of artificial intelligence</dc:title><dc:identifier> pmid:37453047</dc:identifier><dc:identifier> doi:10.1093/eurheartj/ehad448</dc:identifier></item><item><title> Artificial intelligence in detecting left atrial appendage thrombus by transthoracic echocardiography and clinical features: the Left Atrial Thrombus on Transoesophageal Echocardiography (LATTEE) registry</title><link/> https://pubmed.ncbi.nlm.nih.gov/37453044/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230718143148&amp;v=2.17.9.post6+86293ac<description> CONCLUSION: LAT-AI allows accurate prediction of LAT. A LAT-AI-based protocol could be used to guide the decision to perform TOE despite chronic OAC. </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> Eur Heart J. 2023 Jul 15:ehad431. doi: 10.1093/eurheartj/ehad431. Online ahead of print.</p><p> <b>ABSTRACT</b> </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> AIMS: Transoesophageal echocardiography (TOE) is often performed before catheter ablation or cardioversion to rule out the presence of left atrial appendage thrombus (LAT) in patients on chronic oral anticoagulation (OAC), despite associated discomfort. A machine learning model [LAT-artificial intelligence (AI)] was developed to predict the presence of LAT based on clinical and transthoracic echocardiography (TTE) features. </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> METHODS AND RESULTS: Data from a 13-site prospective registry of patients who underwent TOE before cardioversion or catheter ablation were used. LAT-AI was trained to predict LAT using data from 12 sites (n = 2827) and tested externally in patients on chronic OAC from two sites (n = 1284). Areas under the receiver operating characteristic curve (AUC) of LAT-AI were compared with that of left ventricular ejection fraction (LVEF) and CHA2DS2-VASc score. A decision threshold allowing for a 99% negative predictive value was defined in the development cohort. A protocol where TOE in patients on chronic OAC is performed depending on the LAT-AI score was validated in the external cohort. In the external testing cohort, LAT was found in 5.5% of patients. LAT-AI achieved an AUC of 0.85 [95% confidence interval (CI): 0.82-0.89], outperforming LVEF (0.81, 95% CI 0.76-0.86, P &lt; .0001) and CHA2DS2-VASc score (0.69, 95% CI: 0.63-0.7, P &lt; .0001) in the entire external cohort. Based on the proposed protocol, 40% of patients on chronic OAC from the external cohort would safely avoid TOE. </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> CONCLUSION: LAT-AI allows accurate prediction of LAT. A LAT-AI-based protocol could be used to guide the decision to perform TOE despite chronic OAC.</p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/37453044/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230718143148&v=2.17.9.post6+86293ac">37453044</a> | DOI: <a href=https://doi.org/10.1093/eurheartj/ehad431>10.1093/eurheartj/ehad431</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:37453044</guid><pubDate> Sat, 15 Jul 2023 06:00:00 -0400</pubDate><dc:creator> Konrad Pieszko</dc:creator><dc:creator> Jarosław Hiczkiewicz</dc:creator><dc:creator> Katarzyna Łojewska</dc:creator><dc:creator> Beata Uziębło-Życzkowska</dc:creator><dc:creator> Paweł Krzesiński</dc:creator><dc:creator> Monika Gawałko</dc:creator><dc:creator> Monika Budnik</dc:creator><dc:creator> Katarzyna Starzyk</dc:creator><dc:creator> Beata Wożakowska-Kapłon</dc:creator><dc:creator> Ludmiła Daniłowicz-Szymanowicz</dc:creator><dc:creator> Damian Kaufmann</dc:creator><dc:creator> Maciej Wójcik</dc:creator><dc:creator> Robert Błaszczyk</dc:creator><dc:creator> Katarzyna Mizia-Stec</dc:creator><dc:creator> Maciej Wybraniec</dc:creator><dc:creator> Katarzyna Kosmalska</dc:creator><dc:creator> Marcin Fijałkowski</dc:creator><dc:creator> Anna Szymańska</dc:creator><dc:creator> Mirosław Dłużniewski</dc:creator><dc:creator> Michał Kucio</dc:creator><dc:creator> Maciej Haberka</dc:creator><dc:creator> Karolina Kupczyńska</dc:creator><dc:creator> Błażej Michalski</dc:creator><dc:creator> Anna Tomaszuk-Kazberuk</dc:creator><dc:creator> Katarzyna Wilk-Śledziewska</dc:creator><dc:creator> Renata Wachnicka-Truty</dc:creator><dc:creator> Marek Koziński</dc:creator><dc:creator> Jacek Kwieciński</dc:creator><dc:creator> Rafał Wolny</dc:creator><dc:creator> Ewa Kowalik</dc:creator><dc:creator> Iga Kolasa</dc:creator><dc:creator> Agnieszka Jurek</dc:creator><dc:creator> Jan Budzianowski</dc:creator><dc:creator> Paweł Burchardt</dc:creator><dc:creator> Agnieszka Kapłon-Cieślicka</dc:creator><dc:creator> Piotr J Slomka</dc:creator><dc:date> 2023-07-15</dc:date><dc:source> European heart journal</dc:source><dc:title> Artificial intelligence in detecting left atrial appendage thrombus by transthoracic echocardiography and clinical features: the Left Atrial Thrombus on Transoesophageal Echocardiography (LATTEE) registry</dc:title><dc:identifier> pmid:37453044</dc:identifier><dc:identifier> doi:10.1093/eurheartj/ehad431</dc:identifier></item><item><title> Diagnostic management of acute pulmonary embolism: a prediction model based on a patient data meta-analysis</title><link/> https://pubmed.ncbi.nlm.nih.gov/37452732/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230718143148&amp;v=2.17.9.post6+86293ac<description> CONCLUSION: The present model provides an absolute, individualized probability of PE presence in a broad population of patients with suspected PE, with very good discrimination and calibration. Its clinical utility needs to be evaluated in a prospective management or impact study. </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> Eur Heart J. 2023 Jul 15:ehad417. doi: 10.1093/eurheartj/ehad417. Online ahead of print.</p><p> <b>ABSTRACT</b> </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> AIMS: Risk stratification is used for decisions regarding need for imaging in patients with clinically suspected acute pulmonary embolism (PE). The aim was to develop a clinical prediction model that provides an individualized, accurate probability estimate for the presence of acute PE in patients with suspected disease based on readily available clinical items and D-dimer concentrations. </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> METHODS AND RESULTS: An individual patient data meta-analysis was performed based on sixteen cross-sectional or prospective studies with data from 28 305 adult patients with clinically suspected PE from various clinical settings, including primary care, emergency care, hospitalized and nursing home patients. A multilevel logistic regression model was built and validated including ten a priori defined objective candidate predictors to predict objectively confirmed PE at baseline or venous thromboembolism (VTE) during follow-up of 30 to 90 days. Multiple imputation was used for missing data. Backward elimination was performed with a P-value &lt;0.10. Discrimination (c-statistic with 95% confidence intervals [CI] and prediction intervals [PI]) and calibration (outcome:expected [O:E] ratio and calibration plot) were evaluated based on internal-external cross-validation. The accuracy of the model was subsequently compared with algorithms based on the Wells score and D-dimer testing. The final model included age (in years), sex, previous VTE, recent surgery or immobilization, haemoptysis, cancer, clinical signs of deep vein thrombosis, inpatient status, D-dimer (in µg/L), and an interaction term between age and D-dimer. The pooled c-statistic was 0.87 (95% CI, 0.85-0.89; 95% PI, 0.77-0.93) and overall calibration was very good (pooled O:E ratio, 0.99; 95% CI, 0.87-1.14; 95% PI, 0.55-1.79). The model slightly overestimated VTE probability in the lower range of estimated probabilities. Discrimination of the current model in the validation data sets was better than that of the Wells score combined with a D-dimer threshold based on age (c-statistic 0.73; 95% CI, 0.70-0.75) or structured clinical pretest probability (c-statistic 0.79; 95% CI, 0.76-0.81). </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> CONCLUSION: The present model provides an absolute, individualized probability of PE presence in a broad population of patients with suspected PE, with very good discrimination and calibration. Its clinical utility needs to be evaluated in a prospective management or impact study. </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> REGISTRATION: PROSPERO ID 89366.</p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/37452732/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230718143148&v=2.17.9.post6+86293ac">37452732</a> | DOI: <a href=https://doi.org/10.1093/eurheartj/ehad417>10.1093/eurheartj/ehad417</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:37452732</guid><pubDate> Sat, 15 Jul 2023 06:00:00 -0400</pubDate><dc:creator> Nick van Es</dc:creator><dc:creator> Toshihiko Takada</dc:creator><dc:creator> Noémie Kraaijpoel</dc:creator><dc:creator> Frederikus A Klok</dc:creator><dc:creator> Milou AM Stals</dc:creator><dc:creator> Harry R Büller</dc:creator><dc:creator> D Mark Courtney</dc:creator><dc:creator> Yonathan Freund</dc:creator><dc:creator> Javier Galipienzo</dc:creator><dc:creator> Grégoire Le Gal</dc:creator><dc:creator> Waleed Ghanima</dc:creator><dc:creator> Menno V Huisman</dc:creator><dc:creator> Jeffrey A Kline</dc:creator><dc:creator> Karel GM Moons</dc:creator><dc:creator> Sameer Parpia</dc:creator><dc:creator> Arnaud Perrier</dc:creator><dc:creator> Marc Righini</dc:creator><dc:creator> Helia Robert-Ebadi</dc:creator><dc:creator> Pierre-Marie Roy</dc:creator><dc:creator> Phil S Wells</dc:creator><dc:creator> Kerstin de Wit</dc:creator><dc:creator> Maarten van Smeden</dc:creator><dc:creator> Geert-Jan Geersing</dc:creator><dc:date> 2023-07-15</dc:date><dc:source> European heart journal</dc:source><dc:title> Diagnostic management of acute pulmonary embolism: a prediction model based on a patient data meta-analysis</dc:title><dc:identifier> pmid:37452732</dc:identifier><dc:identifier> doi:10.1093/eurheartj/ehad417</dc:identifier></item><item><title> Heart failure and socioeconomic status: global differences and inequalities</title><link/> https://pubmed.ncbi.nlm.nih.gov/37452730/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230718143148&amp;v=2.17.9.post6+86293ac<description> No abstract </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> Eur Heart J. 2023 Jul 15:ehad410. doi: 10.1093/eurheartj/ehad410. Online ahead of print.</p><p> <b>NO ABSTRACT</b></p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/37452730/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230718143148&v=2.17.9.post6+86293ac">37452730</a> | DOI: <a href=https://doi.org/10.1093/eurheartj/ehad410>10.1093/eurheartj/ehad410</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:37452730</guid><pubDate> Sat, 15 Jul 2023 06:00:00 -0400</pubDate><dc:creator> Rocco Vergallo</dc:creator><dc:creator> Carlo Patrono</dc:creator><dc:date> 2023-07-15</dc:date><dc:source> European heart journal</dc:source><dc:title> Heart failure and socioeconomic status: global differences and inequalities</dc:title><dc:identifier> pmid:37452730</dc:identifier><dc:identifier> doi:10.1093/eurheartj/ehad410</dc:identifier></item></channel></rss>